RupeesMatter India | A blog on finance, investments, loans, personal loan, home loan, stock market and mutual funds in India

Reliance Mutual Fund has reduced exposure to Engineering Capital Goods, Metals Mining and Cement Construction sectors while has increased to Banking Financial Services, Pharmaceuticals and Utilities sectors.

Aurobindo Pharma Ltd has received tentative approval from the US Food and Drug Administration for Perindopril Erbumine tablets and Escitalopram Oxalate oral solution. The tablets and oral solution are indicated for the treatment of hypertension

Aurobindo Pharma had touched an intraday high of Rs 122.45 and an intraday low of Rs 108. At 2:15 pm, the share was quoting at Rs 118, up Rs 9.55, or 8.81%. According to agencies, Eli Lilly has sued Aurobindo and Lupin for patent violation, reports CNBCTV18.

Aurobindo Pharma received USFDA approval for the Perindopril Erbumine tablets and Oral anti-depressants

US-based pharma giant Eli Lilly has filed cases against Indian drug makers Aurobindo Pharma and Lupin, alleging infringement of patent of its anti-depressant drug Cymbalta.

New Delhi, Dec 3 Ranbaxy Laboratories Ltd announced that it has signed an exclusive agreement with BioPro Pharmaceutical Inc for marketing a brain tumor drug – Gliadel- in India.

Dr Reddy’s Laboratories has won contracts for supply of seven active pharmaceutical ingredients (APIs) to

Britain’s leading share index closed 1.1% higher on Wednesday, boosted by a rally in defensive drugmakers.

Even as drug regulators the world over are becoming more stringent in scrutinising clinical trials, associations of large pharmaceutical companies in the United States, Europe and Japan have come out

Pharma firm Amrutanjan today said it is planning to enter the European and the US markets shortly